INAF - PT. Indofarma Tbk

Rp 2.900

-90 (-3,10%)

JAKARTA - PT Angkasa Pura (Persero) II or AP II has partnered PT Indofarma (Persero) Tbk (INAF)  to provide a coronavirus (COVID-19) rapid test facility at Soekarno-Hatta Airport's Terminal 3, Cengkareng. This was announced by AP II President Director Muhammad Awaluddin in a press release on Monday (7/12).

According to Mr Awaluddin, the rapid test will be undertaken by PT Farmalab Indo Utama (FIU), a subsidiary of Indofarma. In addition, he said, there will also be drive-through services for air passengers travelling on cars.

Mr Awaluddin added that the testing facility aims to provide comfort and safety for air passengers, both for international and domestic travels. The test costs Rp 85,000 per person. (LK/MS)